BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6132927)

  • 1. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
    Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
    Pipeleers D; Somers G; Gepts W; De Nutte N; De Vroede M
    J Clin Endocrinol Metab; 1979 Oct; 49(4):572-9. PubMed ID: 158032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic polypeptide in somatostatinoma.
    Pinsard D; Odent S; Chadenas D
    Dig Dis Sci; 1986 Apr; 31(4):445-6. PubMed ID: 2869926
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant somatostatinoma: clinical features and metabolic studies.
    Axelrod L; Bush MA; Hirsch HJ; Loo SW
    J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative diagnostic value of the calcium-pentagastrin test versus the tolbutamide test in a patient with a somatostatinoma.
    Budmiger H; Bühler H; Häcki W; Stamm B; Streuli R; Ammann R
    Gastroenterology; 1987 Mar; 92(3):800-4. PubMed ID: 3028898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of duodenal somatostatinoma: diagnostic usefulness of calcium--pentagastrin test.
    Somers G; Pipeleers-Marichal M; Gepts W; Pipeleers D
    Gastroenterology; 1983 Nov; 85(5):1192-8. PubMed ID: 6137434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
    Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
    J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.
    Iguchi H; Kumagai S; Seo IH; Wakasugi H; Hara Y; Abe M
    J Clin Endocrinol Metab; 1988 Jul; 67(1):206-10. PubMed ID: 2897973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of sodium valproate on plasma somatostatin and insulin in humans.
    Kusunoki M; Yamamura T; Ichii S; Fujita S; Nakai T; Utsunomiya J
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1060-3. PubMed ID: 2903170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatinoma syndrome: does a clinical entity exist?
    Stacpoole PW; Kasselberg AG; Berelowitz M; Chey WY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):80-7. PubMed ID: 6297217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic somatostatinoma: presentation with recurrent episodes of severe hyperglycaemia and ketoacidosis.
    Willcox PA; Immelman EJ; Barron JL; Klaff LJ; Harries-Jones EP; Hainsworth M; Millar RP
    Q J Med; 1988 Jul; 68(255):559-71. PubMed ID: 2855274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Somatostatinoma of the pancreas].
    Machado MC; Alves VA; Wakamatsu A; Bacchella T; Cunha JE; Pupo AA; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):222-6. PubMed ID: 2899904
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
    Rehfeld JF
    Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatinoma syndrome accompanied by overproduction of pancreatic polypeptide.
    Nakanome C; Koizumi M; Fujiya H; Akai H; Toyota T; Goto Y; Kameyama J; Miyakawa K; Hanew K
    Tohoku J Exp Med; 1984 Feb; 142(2):201-10. PubMed ID: 6144197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism.
    Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N
    Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the diagnosis of somatostatinoma.
    Somers G; Gepts W; Pipeleers D
    Acta Gastroenterol Belg; 1982; 45(7-8):322-6. PubMed ID: 6301190
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma glucagon in insulinoma.
    Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
    Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose turnover and gluconeogenesis in a patient with somatostatinoma.
    Lowry SF; Burt ME; Brennan MF
    Surgery; 1981 Mar; 89(3):309-13. PubMed ID: 6110246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.